REG - Ingredion Inc. Ingredion Inc. Tate & Lyle PLC - Possible 595 pence all-cash offer for Tate & Lyle

Tate & LyleAnnouncement

14/05/2026 16:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260514:nRSN4112Ea&default-theme=true

RNS Number : 4112E  Ingredion Incorporated  14 May 2026

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS
AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM
INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO
CERTAINTY THAT ANY FIRM OFFER WILL BE MADE

 

14 May 2026

 

Ingredion Incorporated ("Ingredion")

 

Possible 595 pence all-cash offer for Tate & Lyle PLC

 

Ingredion notes the recent announcement by Tate & Lyle PLC ("Tate &
Lyle") regarding a possible offer for the entire issued and to be issued share
capital of Tate & Lyle.

 

Ingredion confirms it has made a non-binding indicative all-cash offer for
Tate & Lyle at a price of 595 pence per Tate & Lyle share (the
"Possible Offer").

 

Under the terms of the Possible Offer, Ingredion would agree that Tate &
Lyle would be permitted to declare and pay two ordinary course dividends in
the form of a final dividend for the financial year ended 31 March 2026 of up
to 13 pence per Tate & Lyle share and an interim dividend for the six
months to 30 September 2026 of up to 7 pence per Tate & Lyle share (the
"Permitted Dividends").

 

Ingredion believes a potential transaction would deliver significant benefits
to customers, consumers, employees and Ingredion shareholders.

 

Ingredion is engaged in discussions and a period of due diligence with Tate
& Lyle to further explore a potential transaction. Discussions are
ongoing, and there can be no certainty that a binding offer will be made.

 

In accordance with Rule 2.5 of the Code, Ingredion reserves the right to make
an offer for Tate & Lyle on less favorable terms than those set out in
this announcement:

(i)         with the agreement or recommendation of the Board of Tate
& Lyle;

(ii)         if a third party announces an offer or possible offer for
Tate & Lyle which, at that date, is of a value less than the Possible
Offer; or

(iii)        following the announcement by Tate & Lyle of a Rule 9
waiver transaction pursuant to the Code or a reverse takeover (as defined in
the Code).

 

Ingredion reserves the right to introduce other forms of consideration and/or
vary the mix or composition of consideration of any offer.

 

Ingredion reserves the right to adjust the terms of the Possible Offer to take
account of the value of any dividend or other distribution or return of value
to Tate & Lyle shareholders which is announced, declared, made or paid by
Tate & Lyle after the date of this announcement, other than the Permitted
Dividends.

 

A further announcement will be made as and when appropriate.

 

In accordance with Rule 2.6(a) of the Code, Ingredion will have until 5.00 pm
(London Time) on 11 June 2026 (the "PUSU deadline") to either announce a firm
intention to make an offer for Tate & Lyle in accordance with Rule 2.7 of
the Code or announce that it does not intend to make such an offer, in which
case the announcement will be treated as a statement to which Rule 2.8 of the
Code applies. This deadline may be extended with the consent of the Takeover
Panel in accordance with Rule 2.6(c) of the Code.

 

A copy of this announcement will be made available, subject to certain
restrictions relating to persons resident in restricted jurisdictions, on
Ingredion's website at https://ir.ingredionincorporated.com/
(https://ir.ingredionincorporated.com/) promptly and in any event by no later
than 12 noon (London time) on 15 May 2026. The content of the website referred
to in this announcement is not incorporated into and does not form part of
this announcement.

 

Inquiries:

 

Ingredion

 

Noah Weiss

Investor Relations

Tel: +1 773 896 5242

Email: investor.relations@Ingredion.com
(mailto:investor.relations@ingredion.com)

 

 J.P. Morgan (Sole Financial Adviser to Ingredion)  Tel: +44 203 493 8000
                                                    Tel: +1 212 270 6000
 Anu Aiyengar / Dwayne Lysaght
 Edouard Metrailler / Patrick Gallagher

 

Hogan Lovells International LLP are retained as legal advisers to Ingredion.

 

This announcement is not intended to, and does not, constitute or form part of
any offer, invitation or the solicitation of an offer to purchase, otherwise
acquire, subscribe for, sell or otherwise dispose of, any securities whether
pursuant to this announcement or otherwise.

 

The distribution of this announcement in jurisdictions outside the United
Kingdom may be restricted by law and therefore persons into whose possession
this announcement comes should inform themselves about, and observe, such
restrictions.  Any failure to comply with the restrictions may constitute a
violation of the securities law of any such jurisdiction.

 

J.P. Morgan Securities plc ("J.P. Morgan"), is authorized in the United
Kingdom by the Prudential Regulation Authority (the "PRA") and regulated by
the PRA and the Financial Conduct Authority. J.P. Morgan is acting as
financial adviser exclusively for Ingredion and no one else in connection with
the matters set out in this announcement and will not regard any other person
as its client in relation to the matters in this announcement and will not be
responsible to anyone other than Ingredion for providing the protections
afforded to clients of J.P. Morgan or its affiliates, or for providing advice
in relation to any matter referred to herein.

 

Rule 2.4 information

 

In accordance with Rule 2.4(c)(iii) of the Code, Ingredion confirms that it is
not aware of any dealings in Tate & Lyle shares that would require
Ingredion, if it were to make an offer, to offer a minimum level, or a
particular form, of consideration under Rule 6 or Rule 11 of the Code (as
appropriate). However, it has not been practicable for Ingredion to make
inquiries of all persons presumed to be acting in concert with it prior to
this announcement in order to confirm whether any details are required to be
disclosed under Rule 2.4(c)(iii). To the extent that any such details are
identified following such inquiries, Ingredion will make an announcement
disclosing such details as soon as practicable, and in any event by no later
than the time it is required to make its Opening Position Disclosure under
Rule 8.1 of the Code.

 

Disclosure requirements of the Takeover Code (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of
any class of relevant securities of an offeree company or of any securities
exchange offeror (being any offeror other than an offeror in respect of which
it has been announced that its offer is, or is likely to be, solely in cash)
must make an Opening Position Disclosure following the commencement of the
offer period and, if later, following the announcement in which any securities
exchange offeror is first identified. An Opening Position Disclosure must
contain details of the person's interests and short positions in, and rights
to subscribe for, any relevant securities of each of (i) the offeree company
and (ii) any securities exchange offeror(s). An Opening Position Disclosure by
a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm
(London time) on the 10th business day following the commencement of the offer
period and, if appropriate, by no later than 3.30 pm (London time) on the 10th
business day following the announcement in which any securities exchange
offeror is first identified. Relevant persons who deal in the relevant
securities of the offeree company or of a securities exchange offeror prior to
the deadline for making an Opening Position Disclosure must instead make a
Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1%
or more of any class of relevant securities of the offeree company or of any
securities exchange offeror must make a Dealing Disclosure if the person deals
in any relevant securities of the offeree company or of any securities
exchange offeror. A Dealing Disclosure must contain details of the dealing
concerned and of the person's interests and short positions in, and rights to
subscribe for, any relevant securities of each of (i) the offeree company and
(ii) any securities exchange offeror(s), save to the extent that these details
have previously been disclosed under Rule 8. A Dealing Disclosure by a person
to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London
time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding,
whether formal or informal, to acquire or control an interest in relevant
securities of an offeree company or a securities exchange offeror, they will
be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by
any offeror and Dealing Disclosures must also be made by the offeree company,
by any offeror and by any persons acting in concert with any of them (see
Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant
securities Opening Position Disclosures and Dealing Disclosures must be made
can be found in the Disclosure Table on the Takeover Panel's website at
www.thetakeoverpanel.org.uk (http://www.thetakeoverpanel.org.uk) , including
details of the number of relevant securities in issue, when the offer period
commenced and when any offeror was first identified. You should contact the
Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any
doubt as to whether you are required to make an Opening Position Disclosure or
a Dealing Disclosure.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  OFDSFFFILEMSEFI



            Copyright 2019 Regulatory News Service, all rights reserved